Livent Co. (NYSE:LTHM) has received a consensus recommendation of “Hold” from the fifteen brokerages that are currently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and five have given a buy rating to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $20.92.
A number of research analysts recently weighed in on LTHM shares. Citigroup boosted their target price on Livent from $22.00 to $25.00 and gave the stock a “neutral” rating in a report on Monday, August 9th. Vertical Research upgraded Livent from a “sell” rating to a “hold” rating and set a $22.00 price target for the company in a research note on Monday, August 9th. Bank of America boosted their price target on Livent from $18.00 to $19.00 and gave the company an “underperform” rating in a research note on Wednesday, August 11th. They noted that the move was a valuation call. Cowen boosted their price target on Livent from $19.00 to $25.00 and gave the company an “outperform” rating in a research note on Monday, August 30th. Finally, Loop Capital boosted their price target on Livent from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Monday, August 23rd.
Several hedge funds have recently made changes to their positions in the stock. Thrivent Financial for Lutherans lifted its position in shares of Livent by 8.3% during the 2nd quarter. Thrivent Financial for Lutherans now owns 130,455 shares of the company’s stock worth $2,526,000 after buying an additional 10,023 shares during the last quarter. Parametric Portfolio Associates LLC increased its holdings in Livent by 26.9% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 590,405 shares of the company’s stock worth $11,430,000 after purchasing an additional 124,971 shares in the last quarter. Comerica Bank increased its holdings in Livent by 0.6% in the 2nd quarter. Comerica Bank now owns 148,803 shares of the company’s stock worth $3,378,000 after purchasing an additional 826 shares in the last quarter. Marshall Wace LLP acquired a new position in Livent in the 2nd quarter worth about $2,936,000. Finally, Marshall Wace North America L.P. acquired a new position in Livent in the 2nd quarter worth about $11,952,000. Institutional investors and hedge funds own 94.13% of the company’s stock.
Livent (NYSE:LTHM) last posted its earnings results on Thursday, August 5th. The company reported $0.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.02 by $0.02. The business had revenue of $102.20 million for the quarter, compared to analyst estimates of $88.80 million. Livent had a positive return on equity of 0.13% and a negative net margin of 3.18%. As a group, analysts anticipate that Livent will post 0.14 EPS for the current fiscal year.
Livent Corp. engages in the production of performance lithium compounds. Its products include battery-grade lithium hydroxide, butyllithium, and purity lithium metal which are used in various performance applications. It operates through the following geographical segments: North America; Europe, Middle East, and Africa; Latin America; and Asia Pacific.
Read More: Why is cost of goods sold important?
Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.